CHELONI, GIULIA
CHELONI, GIULIA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival
2014 Y. Chen; C. Peng; S.A. Abraham; Y. Shan; Z. Guo; N.DeSouza; G. Cheloni; D. Li; T. L. Holyoake and S. Li
Chronic myeloid leukaemia stem cells are sensitive to the pharmacological inhibition of hypoxia inducible factor-1a
2015 Giulia Cheloni
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL
2014 Bono S; Lulli M; Di Gesualdo F; Tusa I; Cheloni G; Rovida E; Dello Sbarba P
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS
2012 I. Tusa; G.Cheloni; NS Gray;X. DengX; E.Rovida; P.Dello Sbarba
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS
2012 G. Cheloni; M. Tanturli; L. Beneforti; E. Rovida; P. Dello Sbarba
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential
2021 Poteti M.; Menegazzi G.; Peppicelli S.; Tusa I.; Cheloni G.; Silvano A.; Mancini C.; Biagioni A.; Tubita A.; Mazure N.M.; Lulli M.; Rovida E.; Dello Sbarba P
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features
2020 Tusa I.; Cheloni G.; Poteti M.; Silvano A.; Tubita A.; Lombardi Z.; Gozzini A.; Caporale R.; Scappini B.; Dello Sbarba P.; Rovida E.
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells
2015 Del Poggetto, E; Tanturli, M; Ben-Califa, N; Gozzini, A; Tusa, I; Cheloni, G; Marzi, I; Cipolleschi, M G; Kashman, Y; Neumann, D; Rovida, E; Dello Sbarba, P
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors
2018 Tusa, I; Cheloni, G; Poteti, M; Gozzini, A; Deng, X; Gray, N S; Li, S; Dello Sbarba, P; Rovida, E
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
2017 Cheloni, G; Tanturli, M; Tusa, I; Desouza, Nh; Shan, Y; Gozzini, A; Mazurier, F; Rovida, E; Li, S; Dello Sbarba, P.
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
2018 Ignazia Tusa,Giulia Cheloni, Martina Poteti, Antonella Gozzini, Ngoc Ho DeSouza, Yi Shan, Xianming Deng, Nathanael S. Gray, Shaoguang Li, Elisabetta Rovida, Persio Dello Sbarba
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction
2017 Cheloni, G; Poteti, M; Bono, S; Masala, E; Mazure, N; Rovida, E; Lulli, M; Dello Sbarba, P
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.
2014 Rovida E; Peppicelli S; Bono S; Bianchini F; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Calorini L; Dello Sbarba P
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells
2013 V. Barbetti; A. Gozzini; G. Cheloni; I. Marzi; E. Fabiani; V. Santini; P. Dello Sbarba; E. Rovida
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival | 2014 | Y. Chen; C. Peng; S.A. Abraham; Y. Shan; Z. Guo; N.DeSouza; G. Cheloni; D. Li; T. L. Holyoake and S. Li | |
| Chronic myeloid leukaemia stem cells are sensitive to the pharmacological inhibition of hypoxia inducible factor-1a | 2015 | Giulia Cheloni | |
| ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL | 2014 | Bono S; Lulli M; Di Gesualdo F; Tusa I; Cheloni G; Rovida E; Dello Sbarba P | |
| ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS | 2012 | I. Tusa; G.Cheloni; NS Gray;X. DengX; E.Rovida; P.Dello Sbarba | |
| GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS | 2012 | G. Cheloni; M. Tanturli; L. Beneforti; E. Rovida; P. Dello Sbarba | |
| Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential | 2021 | Poteti M.; Menegazzi G.; Peppicelli S.; Tusa I.; Cheloni G.; Silvano A.; Mancini C.; Biagioni A.; Tubita A.; Mazure N.M.; Lulli M.; Rovida E.; Dello Sbarba P | |
| In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features | 2020 | Tusa I.; Cheloni G.; Poteti M.; Silvano A.; Tubita A.; Lombardi Z.; Gozzini A.; Caporale R.; Scappini B.; Dello Sbarba P.; Rovida E. | |
| Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells | 2015 | Del Poggetto, E; Tanturli, M; Ben-Califa, N; Gozzini, A; Tusa, I; Cheloni, G; Marzi, I; Cipolleschi, M G; Kashman, Y; Neumann, D; Rovida, E; Dello Sbarba, P | |
| Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors | 2018 | Tusa, I; Cheloni, G; Poteti, M; Gozzini, A; Deng, X; Gray, N S; Li, S; Dello Sbarba, P; Rovida, E | |
| Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. | 2017 | Cheloni, G; Tanturli, M; Tusa, I; Desouza, Nh; Shan, Y; Gozzini, A; Mazurier, F; Rovida, E; Li, S; Dello Sbarba, P. | |
| Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells | 2018 | Ignazia Tusa,Giulia Cheloni, Martina Poteti, Antonella Gozzini, Ngoc Ho DeSouza, Yi Shan, Xianming Deng, Nathanael S. Gray, Shaoguang Li, Elisabetta Rovida, Persio Dello Sbarba | |
| The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction | 2017 | Cheloni, G; Poteti, M; Bono, S; Masala, E; Mazure, N; Rovida, E; Lulli, M; Dello Sbarba, P | |
| The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. | 2014 | Rovida E; Peppicelli S; Bono S; Bianchini F; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Calorini L; Dello Sbarba P | |
| Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells | 2013 | V. Barbetti; A. Gozzini; G. Cheloni; I. Marzi; E. Fabiani; V. Santini; P. Dello Sbarba; E. Rovida |